DCF — ENCOMPASS HEALTH REHABILITATION HOSP
Enterprise Value: $15.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$15.2M
Enterprise Value
$3.9M
PV of Cash Flows
$11.3M
PV of Terminal Value
$18.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $24.6M | $2.1M | 9.0% | $0.7M | $0.6M |
| Year 2 | $25.3M | $2.4M | 10.0% | $0.9M | $0.7M |
| Year 3 | $26.1M | $2.7M | 11.0% | $1.1M | $0.8M |
| Year 4 | $26.9M | $3.0M | 11.0% | $1.2M | $0.9M |
| Year 5 | $27.7M | $3.1M | 11.0% | $1.3M | $0.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $15.2M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$23.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000167656103
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5